Another option for managing continuous glucose data is now available in the United States. Abbott’s Freestyle Libre Pro has been FDA approved. This is the Pro version – not the consumer version. This will allow medical professionals to work with their patients to get and analyze data and make therapy decisions. The consumer version has been submitted to the FDA for approval. Hopefully it won’t take too long.
There are some specific differences of the Libre system, including the consumer version, to other CGMs currently available.
– It requires no calibration.
– Information is not displayed continuously. In the consumer version, you scan the reader device over the sensor at your discretion to get a reading. Fingersticks are eliminated.
-The cost is significantly less, thereby making it available to a consumer group to which the more expensive products are out of reach.
Click here for the complete press release.
Visit Abbott’s website for more information.